RxDoctor Payments Data

Jonathan Riffle, DO

Neurological Surgery · New Orleans, LANPI 1215357603

Payments from drug & device makers

What this record shows

7 manufacturers reported payments, led by Globus Medical at 51.9% of the total. Reporting peaked in 2022 at $3,380 and has fallen 82.3% since, to $598 in 2025.

$7,709in general payments, 2019–2025

Across 76 payments — averaging $101.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$4K
  • Medtronic$2K
  • Johnson & Johnson$1K
  • Spine Wave, Inc.$189
  • Wenzel Spine, Inc.$171
  • Theragen, Inc.$128
  • plus $117 from 1 others

What the payments were for

  • Travel & lodging$4,51859%
  • Food & beverage$3,19041%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Globus Medical38$4,001
Medtronic21$2,080
Johnson & Johnson11$1,022
Spine Wave, Inc.2$189
Wenzel Spine, Inc.1$171
Theragen, Inc.2$128
Icotec Medical Inc.1$117

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,709 in reported general payments places this provider in the 60th percentile of 116 neurological surgery providers in Louisiana.

See all neurological surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$102,163
Medicare patients
71
Services billed
265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin15$209
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$154

Paid to pharmacies, not to this prescriber.

Other neurological surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →